Product Information
EMEND 80 MG CAPSULE is a brand product labeled by Merck Sharp & Dohme LLC, priced at $208.9830 per EA under NDC 00006046102. Its NADAC has been published 330 times since Nov 28, 2013.
FDA first approved this application on Mar 26, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the aprepitant market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
80 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006046102
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/22/2025
Active Ingredients
APREPITANTApproval Type
New Drug (NDA)
FDA Application
NDA021549FDA Approved
3/26/2003
TE Code
AB
On Market Since
3/26/2003
Pharmacological Classes
Price Statistics
The NADAC for EMEND 80 MG CAPSULE has been published 330 times since Nov 28, 2013, and over the history we have for it it has risen 89.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $208.9830 per EA |
|---|---|
| All-time high | $210.6048 (Jan 16, 2019) |
| All-time low | $110.0237 (Nov 28, 2013) |
| 52-week high | $208.9830 |
| 52-week low | $208.9830 |
| Median price | $191.6465 |
| Average price | $172.5423 |
| Largest weekly change | +9.9% (Jan 18, 2017) |
| Weeks tracked | 330 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
-0.8%
5Y
-0.8%
All
+89.9%
Last surveyed Jan 14, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Merck Sharp & Dohme LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
aprepitant market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Substance P/Neurokinin-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EMEND 80 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EMEND 80 MG CAPSULE, manufactured by Merck Sharp & Dohme LLC, is $208.9830 per EA (NDC 00006046102), effective Jan 14, 2026.
How has the price of EMEND 80 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EMEND 80 MG CAPSULE has risen 89.9%. It has been tracked across 330 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EMEND 80 MG CAPSULE?
Since Nov 28, 2013, the NADAC for EMEND 80 MG CAPSULE has ranged from a low of $110.0237 (Nov 28, 2013) to a high of $210.6048 (Jan 16, 2019), with a median of $191.6465 per EA.
Are there cheaper alternatives to EMEND 80 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, APREPITANT 80 MG CAPSULE, is $76.3524 per EA — about 63% below EMEND 80 MG CAPSULE.
Who manufactures EMEND 80 MG CAPSULE?
EMEND 80 MG CAPSULE (NDC 00006046102) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.